KM Research Hub
← 返回结果库查看论文详情PubMed ↗
READ-ONLY DIGITIZATION RESULT

Impact of minimal residual disease on the outcome of hematopoietic stem cell transplantation for childhood acute lymphoblastic leukemia within the FORUM trial.

Haematologica · 2026-Jan-01 · PMID 40820816

Panel E提取完成待 EXE 对齐验证

Overall Survival

Figure 3. Outcome by minimal residual disease status at the time of hematopoietic stem cell transplantation according to immunophenotype. Overall survival (OS) (A), event-free survival (EFS) (B), cumulative incidence of relapse (CIR) (C), and transplant-related mortality (TRM) (D) for patients affected with B-lineage acute lymphoblastic leukemia (ALL). OS (E), EFS (F), CIR (G), and TRM (H) for those affected with T-lineage ALL. HSCT: hematopoietic stem cell transplantation; MRD: minimal residual disease; PCR: polymerase chain reaction; pos: positive; SE: Standard Error; TBI: total body irradiation; VP16: etoposide.

算法:legacy-0.5.0引擎:enhanced-linux
质量评分0.51
质量通过是
预期曲线2
实际曲线2
X 范围-
Y 范围-

曲线数据

网页最多预览 200 行,完整数据请下载 CSV 或 JSON。

当前面板没有可预览的 `curves_mapped.csv` 数据。
历史版本(1)

重跑只新增版本,不覆盖旧结果;正式可用状态仅授予通过 EXE 基准或人工复核的版本。

版本状态验证曲线时间
legacy-0.5.0complete待验证22026-07-23T17:21:48+00:00